Researchers have identified a promising new weapon against triple-negative breast cancer, one of the most aggressive forms of ...
Researchers found an antibody that seems to play a role in people with better lung cancer prognoses, but turning it into a ...
In patients with cystic fibrosis, CMTX-101, an immune-enabling antibody therapy, lowered four inflammatory biomarkers and ...
Phase 2 clinical trial will evaluate the safety, translational biology, and exploratory clinical efficacy of VYD2311 in people with Long COVID or ...
A trial was about to launch for a vaccine that would ward off the HIV virus. It would be an incredible breakthrough. Then it ...
For reference, ADAMTS13 is a key regulator of blood clotting, preventing excessive clot formation in normal circulation. Its primary function is to cleave vWF, a large protein that helps platelets ...
In this important quantitative study of HIV-1 evolution in humans and rhesus macaques, selection coefficients are inferred at scale over the HIV genome. Selection coefficients are similar in humans ...
Introduction: Human papillomavirus (HPV) infection represents a significant public health concern due to its strong association with various cancers and other diseases. The development and ...
Over the course of a few years, a small percentage of individuals with HIV-1 develop broadly neutralizing antibodies (bnAbs) capable of neutralizing diverse viruses. Although hundreds of antibodies ...
Researchers from the Shenzhen Institutes of Advanced Technology (SIAT), Chinese Academy of Sciences, along with multiple collaborators, have developed a compact diagnostic platform that can evaluate ...
BioNTech and Bristol Myers Squibb have announced a partnership for the global co-development and co-commercialization of BNT327, a bispecific antibody targeting PD-L1 and VEGF-A, which aims to improve ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results